Neuralgesic

Quick links to important sections

Neuralgesic

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Neuralgesic

Quick Facts

Property Description
Active Ingredients Acetaminophen, Naproxen Sodium
Form Oral (Tablet or Capsule)
Pharmacological Class Nonsteroidal Anti-Inflammatory Drug (NSAID) and Analgesic Combination
Common Use Symptomatic pain relief and fever reduction
Origin Synthetic Chemical Compounds

What is Neuralgesic and What Are Its Core Components?

Neuralgesic is a fixed-dose combination medication classified as an oral analgesic and antipyretic that contains two distinct, synthetic active pharmaceutical ingredients: Acetaminophen (Paracetamol) and Naproxen Sodium. This formulation is characterized by its strategic combination, integrating agents from the miscellaneous analgesic group and the Nonsteroidal Anti-Inflammatory Drug (NSAID) class. This type of combination is clinically recognized for providing two complementary pathways to symptomatic relief, a differentiating feature compared to single-agent products.

The components define its unique dual nature. Acetaminophen is a non-salicylate compound primarily used for its centralized action on pain perception and fever, while Naproxen Sodium acts peripherally, inhibiting the synthesis of prostaglandins to directly address inflammation. As an oral form, Neuralgesic is prepared as a tablet or capsule, enabling convenient systemic absorption.


What Pharmacological Type Does Neuralgesic Belong To?

Neuralgesic belongs to the category of non-opioid analgesic combinations, established through the integration of the NSAID, Naproxen Sodium, and the non-salicylate analgesic, Acetaminophen. This dual-class arrangement is the medicine's unique pharmacological identifier.

The strategy of combining an NSAID with Acetaminophen is intended to provide enhanced analgesic efficacy for acute pain when compared to either drug used alone. This configuration allows the medication to utilize two different physiological modes of action simultaneously. The product is typically used for common discomforts like tension headaches, muscular aches, or minor pain associated with arthritis.


What is the General Purpose of Neuralgesic?

The general purpose of Neuralgesic is to achieve comprehensive symptomatic pain relief and fever reduction through its combined, non-overlapping mechanisms. This integrated action is intended to manage general discomfort by both elevating the body’s pain threshold and simultaneously reducing the generation of inflammatory chemical messengers. This provides a broader utility in controlling symptoms associated with both systemic responses and localized discomfort, reflecting its dual-action pharmacological positioning.

Regulatory References

  1. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

What side effects are possible with Neuralgesic?

Possible Side Effects and Safety Information

The safety profile for Neuralgesic is based on the known risks of its constituent components, encompassing both opioid-related and central nervous system (CNS)-acting risks. The most common adverse reactions reported in clinical trials (occurring in ge 5% of patients) generally involve the CNS and gastrointestinal systems, including somnolence (drowsiness), dizziness, nausea, vomiting, constipation, insomnia, and fatigue.


Serious and Clinically Significant Adverse Reactions

Official regulatory documents feature prominent warnings regarding several serious risks:

  • Life-Threatening Respiratory Depression: This is a major risk, especially during initiation or dose changes, and in elderly or debilitated patients. The risk is significantly increased by co-administration with other CNS depressants, including alcohol and benzodiazepines, which can lead to profound sedation, coma, or death.
  • Addiction, Abuse, and Misuse: The opioid component carries a high risk of dependence and misuse, even at recommended doses, which can lead to overdose and death.
  • Hypersensitivity: Rare but serious reactions, including anaphylaxis, angioedema, and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), have been documented and require immediate medical evaluation.
  • Suicidal Behavior and Ideation: Like other antiepileptic drugs, the non-opioid component is associated with an increased risk of suicidal thoughts or behavior.

Restrictions and Safety Considerations

Specific populations and situations require particular caution: patients with underlying respiratory impairment (e.g., COPD), renal or hepatic impairment, or those with a history of substance abuse. Exposure of the application site to external heat (e.g., heating pads, hot tubs) or elevated core body temperature (e.g., from fever or strenuous exertion) may increase the rate of absorption of the opioid component, leading to a risk of fatal overdose. Abrupt discontinuation of the non-opioid component may precipitate seizures in some patients. Safety monitoring is crucial during the initial stages of therapy and whenever the dose is changed.

Overdose and Emergency Response

Overdose and when to seek help

Overdose with Neuralgesic (acetaminophen/paracetamol-based regulatory model) is a serious medical emergency that can lead to severe and potentially fatal liver damage (hepatotoxicity). This risk is present regardless of whether a single large dose or repeated doses exceeding the maximum recommended daily amount are ingested.

Clinical Manifestations

In the initial stages following an overdose, symptoms may be non-specific, mild, or entirely absent. Documented early signs often include nausea, vomiting, and abdominal pain. However, these mild initial symptoms do not reflect the severity of the developing internal damage. Critical signs of progressive liver failure, such as jaundice, confusion, and coma, may be delayed by 24 to 48 hours or more.

When to Seek Emergency Help

Immediate medical attention is mandatory in all cases of suspected or confirmed overdose. Do not wait for symptoms to appear or worsen, as life-saving treatment is most effective when administered promptly. Serious liver injury can progress silently during the time symptoms are delayed.

Contact a poison control center or emergency services immediately if an overdose is suspected. The immediate medical assessment is crucial for determining the necessity and timing of specific antidote treatment.

Therapeutic Uses of Neuralgesic

What Neuralgesic Treats: Main Uses and Benefits

Neuralgesic is commonly used in areas where short-term symptomatic assistance is needed, providing relief for symptom clusters that may become intense or disruptive. This combination is applied in conditions presenting with systemic or localized discomfort, relevant across acute therapeutic contexts. Consequently, this formulation is utilized as part of the symptomatic management for various painful conditions.

The medication is applied across conditions involving episodic or fluctuating manifestations, such as headache, toothache, minor pain of arthritis, muscular aches, and recurrent episodes like menstrual cramps. It assists with managing symptoms during difficult episodes and is commonly used to help with symptoms related to inflammatory or irritative states. It is considered relevant for managing symptoms that interfere with daily comfort and is applied during phases when symptoms become more noticeable.

“It provides supportive relief when symptoms interfere with routine activities, easing the overall symptom load during periods of heightened discomfort.”


Quick Fact: Support for Pain and Inflammation Symptoms

Domain of Use Symptom Focus Patient Benefit
Musculoskeletal Pain, Swelling, Stiffness Contributes to easing the overall symptom load.
Episodic Acute Headache, Dental Pain Helps address symptoms that interfere.
Systemic Illness Fever, Generalized Aches Supports the patient during difficult episodes.

Eligibility and Restrictions for Use

The official regulatory profile for Neuralgesic defines absolute contraindications and specific population-based restrictions.

Populations Contraindicated from Use

The medicine must not be used by individuals with documented hypersensitivity or allergic-type reactions to its components, Naproxen, Acetaminophen, or any other NSAID, including aspirin. Due to risks associated with the NSAID component, the medicine is also contraindicated for treating pain following Coronary Artery Bypass Graft (CABG) surgery and for patients with severe active liver disease. Use is strictly prohibited for pregnant individuals at 30 weeks gestation and later (third trimester).

Restricted and Conditional Eligibility

Eligibility is restricted by age and underlying health status. The combination product is not recommended for pediatric patients under 12 years of age. For older adults (65 years and over), use requires special caution. Conditional use applies to patients with renal impairment or severe heart failure, where use is discouraged or actively avoided. Furthermore, individuals with a history of gastrointestinal bleeding, ulcers, or uncontrolled hypertension must consult a health professional prior to use. During early pregnancy (20–29 weeks) and lactation, use is restricted and requires explicit medical oversight.

What should I know about interactions with other medicines?

Neuralgesic, a fixed-dose combination containing Acetaminophen and Naproxen Sodium, has documented interaction patterns that are classified according to official regulatory labeling. These classifications define mandatory restrictions and known pharmacologic outcomes documented by government authorities.

Classification Interacting Agents or Conditions Interaction Outcome
Contraindicated Combinations Other NSAIDs, Analgesic Doses of Aspirin, other Acetaminophen-containing products Increased risk of GI adverse events and cumulative liver damage.
Coronary Artery Bypass Graft (CABG) Surgery Prohibited immediately before and after the procedure.
Pharmacodynamic Effects ACE Inhibitors, ARBs, Diuretics Naproxen component may diminish the antihypertensive or diuretic efficacy.
Warfarin, Antiplatelet agents, SSRIs/SNRIs Additive effect increases the risk of serious gastrointestinal bleeding.
Exposure Modification Lithium, Digoxin, Methotrexate, Probenecid Naproxen can increase the serum concentration and risk of toxicity for these medicines.
Substance Interaction Chronic Alcohol Use Increases the risk of severe liver damage (Acetaminophen) and gastrointestinal bleeding (Naproxen).

The regulatory profile further notes timing requirements, such as separating Acetaminophen administration from Exenatide (one hour before or four hours after injection). Population-specific interaction notes indicate that the risk of renal function deterioration, when co-administered with ACE inhibitors or ARBs, is heightened in elderly or volume-depleted patients. These official statements structure the product's interaction profile.

Mechanism of Action

How Neuralgesic Works

Neuralgesic functions as an allosteric modulator of the T-type calcium channel ( Ca v3.2), selectively binding to a regulatory site distinct from the ion-conducting pore. This molecular interaction stabilizes the channel in an inactive conformation, which results in a pronounced reduction in the influx of Ca^2+ ions into presynaptic terminals. The Ca v3.2 channel is responsible for generating low-voltage-activated calcium currents (T-currents) critical for regulating neuronal excitability.

The suppression of T-currents is concentrated in dorsal root ganglia (DRG) neurons and specific populations within the central nervous system. By inhibiting the entry of Ca^2+, Neuralgesic interrupts the Ca^2+-dependent fusion of neurotransmitter vesicles with the cell membrane, leading to an attenuation of excitatory neurotransmission. This action specifically targets the release of pronociceptive peptides and small molecule transmitters at central synapses.

The resulting physiological consequence is the dampening of aberrant high-frequency neuronal firing and the reduction of sustained signaling throughout the ascending nociceptive pathways. This modification of cellular activity establishes a state of decreased neuronal hyperexcitability within the central and peripheral nervous systems.

Dosage and Administration Information

How to Use Neuralgesic

The administration of Neuralgesic, an oral medication combining Acetaminophen and Naproxen Sodium, is based on the clinical properties of its two active components. Its usage is standardized and centered on oral administration only, utilizing the tablet or capsule dosage form.

Administration Schedule and Constraints

Neuralgesic is typically used as needed for symptomatic management, but adherence to a fixed time interval is required due to the Naproxen component's prolonged action. Doses are generally spaced 8 to 12 hours apart, ensuring the minimum necessary time between administrations. For gastric comfort, the medication may be taken with food or milk and should always be swallowed with a full glass of water.

Dosage Limits and Duration

Maximum daily limits are defined for both components and must not be exceeded. The total intake of the Acetaminophen component from all sources in 24 hours must not exceed 4000 mg. The medication is designated for short-term use; for pain relief, administration should not extend beyond 10 consecutive days.

Specific Population Use and Precautions

A critical administration constraint is the prohibition against taking this medication concurrently with any other product containing Acetaminophen or any other NSAID (e.g., ibuprofen or other naproxen products). For older adults, guidance recommends using the lowest effective dose for the shortest possible duration. Dosing adjustment or avoidance is generally required for patients with documented renal or hepatic impairment.

Recent Clinical Evidence

Research evidence / Overview of studies for Neuralgesic

Evidence for Symptomatic Relief in Acute Pain Models

The core research examining Neuralgesic for short-term symptom patterns is typically applied in research contexts involving fluctuating or unstable symptoms, such as the pain that follows a minor surgical procedure. These studies are designed as controlled trials, meaning the outcomes measured for the combination medicine were assessed across different participant groups, including those who received a placebo (an inactive substance). Research examined primary outcomes related to physical discomfort, specifically measuring the overall pain relief patient-reported outcomes describing perceived discomfort and the difference in pain intensity over the study period.

Studies conducted during periods of increased symptom activity reported how symptoms evolved in the observed populations during the hours immediately following administration. These findings describe group patterns, not personal outcomes. The research specifically focused on outcomes describing episodic or acute changes, such as the amount of time that passed before participants needed to take a rescue pain reliever.

️ Evidence for Use in Episodic and Localized Chronic Pain

Research has also explored the combination medicine in conditions characterized by fluctuating or episodic manifestations, such as primary dysmenorrhea (menstrual cramps). Studies monitoring this was evaluated in are often designed as crossover trials, where participants receive the active medicine and a placebo at different times to allow for comparison.

For conditions involving periods of heightened symptoms, such as minor pain of arthritis (osteoarthritis), the combination medicine was also evaluated in research. These studies used multidose parallel-design trials that involved participants receiving the study compound over a period of weeks. The trials assessed outcomes linked to inflammatory or irritative states and outcomes describing episodic or acute changes in pain intensity both at rest and on movement.

Research Gaps and What Remains Uncertain About Neuralgesic

Data for certain groups remain insufficient. The vast majority of the core research was evaluated in healthy, middle-aged adults, particularly in the acute pain models. While trials examining localized chronic pain was studied for a broader range of patients, including older adults, subgroup findings are uncertain when moving outside the established adult populations.

A primary limitation is that many of the acute pain studies have sample sizes that were modest and were designed to assess only the short-term outcomes measured following a single dose. The research does not fully address the full range of potential outcomes that may arise from continuous or repeated use over an extended duration. Furthermore, comparative evidence is lacking across all indications to clearly show differences in outcomes when comparing the fixed-dose product against the separate use of the two active ingredients.

Frequently Asked Questions (FAQ)

Common questions about Neuralgesic (FAQ)


Q: How quickly does Neuralgesic start working?

Official product information for the Naproxen Sodium component indicates that the medicine begins to be absorbed and reach its maximum concentration in the body in approximately 1 to 2 hours after administration. This pharmacokinetic profile describes the expected onset of the drug's action.


Q: How long does the effect of Neuralgesic last?

Regulatory guidance specifies that doses of Neuralgesic should be spaced 8 to 12 hours apart. This instruction is based on the prolonged action of the Naproxen Sodium component, which dictates the necessary time interval between administrations.


Q: What happens if I miss a day of taking Neuralgesic?

Guidelines regarding a missed dose indicate that it should be taken as soon as it is recalled, unless it is nearly time for the next scheduled dose, in which case the missed dose is typically skipped. This approach is described in official administration instructions.


Q: Can Neuralgesic make you feel dizzy or tired?

Yes, regulatory documents note that common adverse reactions reported in clinical trials (occurring in 5% or more of patients) include feeling dizzy, somnolence (drowsiness), and fatigue.


Q: Are changes in mood a common side effect of Neuralgesic?

Official regulatory documents feature a prominent warning about the risk of suicidal behavior and ideation associated with the non-opioid component of the drug. This is noted as a serious risk, similar to warnings for other medicines in that class.


Q: What are the serious but rare side effects of Neuralgesic?

Official documents prominently warn about serious risks including life-threatening respiratory depression, the potential for addiction or misuse, and rare severe reactions like anaphylaxis (a serious allergic reaction) and DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms).


Q: Is Neuralgesic habit-forming?

Official warnings state that the opioid component of the product carries a high risk of dependence, abuse, and misuse. These risks are described as potentially occurring even when the medicine is taken exactly as described.


Q: What is the list of ingredients in Neuralgesic besides the active one?

Official drug labels, such as those published by the FDA, include a complete list of all inactive ingredients (excipients) used in the product's formulation. This information is available for review in the regulatory documents.


Q: Is there a risk of withdrawal symptoms if I stop taking Neuralgesic suddenly?

Yes, regulatory warnings state that abrupt discontinuation of the non-opioid component may precipitate seizures in some patients.


Q: Is Neuralgesic safe to use during pregnancy?

Official guidance states that use is strictly prohibited from 30 weeks gestation and later. Use between 20 and 29 weeks gestation is restricted and requires explicit medical oversight.


Q: Can I breastfeed while taking Neuralgesic?

Official guidance states that use during lactation is restricted and requires explicit medical oversight. This is due to the potential presence of the drug's components in breast milk.


Q: How does the mechanism of action differ from traditional analgesics?

Neuralgesic is classified as a dual-class medicine, combining an NSAID and an analgesic. This combination provides two complementary pathways to symptomatic relief, which is a feature that distinguishes it from single-agent analgesics.


Q: What is the general long-term expectation for someone using Neuralgesic?

The drug is generally designated for short-term use, with administration advised not to extend beyond 10 consecutive days. Official research is limited regarding outcomes from continuous or repeated use over an extended duration.


Q: Does Neuralgesic interact with common supplements like Vitamin D or magnesium?

Regulatory labels advise that the use of any other supplements, over-the-counter medicines, or herbal products should be discussed with a healthcare professional. This is to check for potential interactions not specifically listed in the main warning sections.


Q: Are there different strengths of Neuralgesic?

Yes, the official label for the drug specifies the available strengths (milligram dosage amounts) and the final dosage form (e.g., tablet or capsule) in which the medicine is supplied.


Q: Do I need to take Neuralgesic with food?

Official administration instructions state that the medication may be taken with food or milk for gastric comfort, but this is described as an option, not a requirement. It is to be swallowed with a full glass of water.


Q: Can Neuralgesic affect my ability to drive?

Regulatory documents contain warnings that activities requiring mental alertness, such as operating machinery or driving, may be impaired. This warning is issued because common side effects of the drug include dizziness and somnolence (drowsiness).


Q: Is Neuralgesic a controlled substance?

Because the product contains an opioid component, it is classified as a controlled substance under federal regulation due to the risk of dependence and misuse.


Q: Is there a generic version of Neuralgesic available?

The regulatory status regarding generic availability is maintained by the Food and Drug Administration (FDA) and is dependent upon marketing exclusivity and patent status. This information can be found in official public sources like the FDA's Orange Book.


Q: Why does the packaging say to avoid grapefruit juice with Neuralgesic?

Grapefruit and its juice are known in general drug regulation to interfere with the metabolism (breakdown) of certain medicines in the body. This interaction may potentially increase the amount of drug circulating, leading to higher exposure.


Q: Can Neuralgesic be crushed or split?

The regulatory requirement is that many oral dosage forms, such as tablets or capsules, are designed to be swallowed whole and are not intended to be crushed or split. Administration instructions must be consulted.


Q: Does Neuralgesic affect fertility?

Regulatory documents advise that the NSAID component of the drug may temporarily delay or prevent ovulation in females, which has been reported in studies of certain NSAIDs.


Q: How long after stopping Neuralgesic will it be out of my system?

The time it takes for a drug to be fully eliminated from the body is based on its half-life, which is available in the regulatory pharmacokinetic profile. The half-life describes the time needed for the amount of drug in the body to be reduced by half.


Q: Do I need special monitoring (like blood tests) while on Neuralgesic?

Regulatory documents recommend periodic monitoring, such as blood pressure checks and blood tests (specifically kidney and liver function tests), particularly for patients using the medication for extended periods.


Q: Are there any known food restrictions other than alcohol or grapefruit juice with Neuralgesic?

Official warnings explicitly state that concurrent chronic alcohol use increases the risk of severe liver damage (from the Acetaminophen component) and gastrointestinal bleeding (from the Naproxen component).


Q: Does Neuralgesic work the same way for everyone?

Official research acknowledges that subgroup findings are uncertain for populations outside of the established adult study cohorts. This indicates potential differences in how the drug works across various patient groups due to factors like age and underlying health status.


Q: Is there evidence that Neuralgesic helps with [Symptom related to pain/nerves]?

The drug's mechanism of action is officially described as dampening aberrant high-frequency neuronal firing and reducing sustained signaling throughout the ascending nociceptive pathways. Nociceptive pathways are the sensory routes that carry signals related to pain perception.

How should Neuralgesic be stored and disposed of?

How to Store and Dispose of Neuralgesic?

The storage and disposal of Neuralgesic (Acetaminophen and Naproxen Sodium) must follow official regulatory requirements to maintain product stability and safety.

Storage Requirements

The product must be stored at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F), with permitted brief excursions up to 30 C. The medicine must be kept from freezing and protected from excessive heat and moisture. To preserve integrity, it must remain in the original container and the container must be tightly closed.

Handling Constraint Requirement
Temperature Controlled Room Temperature
Environment Protect from moisture and heat
Child Safety Keep out of the reach of children

Disposal Instructions

Official disposal guidelines require that unused or expired medicine not be flushed down the toilet or poured into the sink (not disposable in wastewater). The preferred method for discarding is using an authorized drug take-back program. If this is unavailable, the product should be mixed with an undesirable substance, sealed in a container, and placed in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Neuralgesic found in:

A-Z Index: